News | Endovascular Aortic Repair | July 08, 2016

Michigan Hospital Employing Conscious Sedation for Aortic Aneurysm Repair

Beaumont Hospital-Royal Oak believed to be the first facility in the state to eliminate general anesthesia for minimally invasive repair

Beaumont Hospital, Michigan, endovascular aortic repair, EVAR, conscious sedation

July 8, 2016 — Kirk Schoenherr, 56, of Clinton Township, Mich., recently became just the second patient at Beaumont Hospital, Royal Oak, to receive conscious sedation for thoracic aortic aneurism repair. Conscious sedation employs a combination of medicines that block pain and allow patients to relax and remain awake during a medical procedure.

 

Read the article "Moderate Sedation Shows Promise for TAVR Patients" 

 

Though many hospitals offer minimally invasive repair of the descending thoracic aorta, it is believed that Beaumont Hospital, Royal Oak, is the only one in the state to combine it with conscious sedation.

Not having to go under general anesthesia was a big relief,” said Schoenherr. “I was more alert afterwards and able to enjoy a greater feeling of awareness, contributing to less anxiety. Being intubated scratches your throat and is painful. And once the tube is out, it’s harder to breath.

“Most importantly, since I wasn’t intubated, I could immediately return to my regular diet,” Schoenherr said.

Schoenherr began experiencing pain related to his aortic ulcer this past Easter. He was at risk for a rupture, which often occurs without warning and leads to sudden death. The problem was diagnosed by emergency center staff at Beaumont Hospital, Troy, and surgically repaired June 1 at Royal Oak.

This multidisciplinary approach to aortic repair combines the expertise of Beaumont’s chief of vascular surgery, O. William Brown, M.D., and cardiac surgeons Alessandro Vivacqua, M.D., and Jeffrey Altshuler, M.D.

 “Conscious sedation eliminates the risks of general anesthesia,” Vivacqua said. “The patient doesn’t have to be intubated or placed on a ventilator. There are no concerns regarding decrease in blood pressure or heart rate. Conscious sedation is safe and much more comfortable.”

Additionally, because the patient is awake during the procedure, the surgical team is able to closely monitor, diagnose and treat possible spinal cord complications, Brown said.

“Beaumont is at the forefront of reducing overall surgical risk and is constantly working to make procedures less invasive,” Brown said.

For more information: www.beaumont.org

 

Related Content for Conscious Sedadtion and TAVR:

VIDEO: Conscious Sedation for TAVR Procedures

VIDEO: The State of TAVR in 2016

Conscious Sedation TAVR Reduced Length-of-Stay and Hospital Costs

Moderate Sedation Shows Promise for TAVR Patients

UTHealth, Memorial Hermann Perform Conscious Sedation TAVR Procedure

Related Content

Videos | Cath Lab| January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab| January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab| November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Videos | Cath Lab| November 08, 2017
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on
Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab| November 06, 2017
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found
Culprit Lesion-Only PCI Improves Outcomes for Cardiogenic Shock Patients Compared to Multivessel PCI
News | Cath Lab| November 01, 2017
November 1, 2017 — Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strateg
Three-Year Quality of Life Improvements Similar for PCI and CABG in Left Main Disease
News | Cath Lab| October 30, 2017
October 30, 2017 — New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left m
Corindus Evaluates Incorporating HeartFlow Technology With CorPath GRX System
Technology | Cath Lab| October 26, 2017
Corindus Vascular Robotics Inc. announced that it will incorporate the HeartFlow FFRct (fractional flow reserve-...
Shockwave Medical Announces $35 Million in New Financing
News | Cath Lab| October 24, 2017
October 24, 2017 — Shockwave Medical reported $35 million in new financing, an extension of the company’s previously
Overlay Init